GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Bristol-Myers Squibb Co (XTER:BRM) » Definitions » Inventories, Raw Materials & Components

Bristol-Myers Squibb Co (XTER:BRM) Inventories, Raw Materials & Components : €0 Mil (As of Dec. 2024)


View and export this data going back to 1998. Start your Free Trial

What is Bristol-Myers Squibb Co Inventories, Raw Materials & Components?

Bristol-Myers Squibb Co's inventories, raw materials & components for the quarter that ended in Dec. 2024 was €0 Mil.


Bristol-Myers Squibb Co Inventories, Raw Materials & Components Historical Data

The historical data trend for Bristol-Myers Squibb Co's Inventories, Raw Materials & Components can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Bristol-Myers Squibb Co Inventories, Raw Materials & Components Chart

Bristol-Myers Squibb Co Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Inventories, Raw Materials & Components
Get a 7-Day Free Trial Premium Member Only Premium Member Only 170.15 309.75 - - -

Bristol-Myers Squibb Co Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Inventories, Raw Materials & Components Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Bristol-Myers Squibb Co Inventories, Raw Materials & Components Calculation

Materials and components scheduled for use in making a product.


Bristol-Myers Squibb Co Business Description

Industry
Address
Route 206 and Province Line Road, Princeton, New Jersey, NJ, USA, 08543
Bristol-Myers Squibb discovers, develops, and markets drugs for various therapeutic areas, such as cardiovascular, cancer, and immune disorders. A key focus for Bristol is immuno-oncology, where the firm is a leader in drug development. Bristol derives close to 70% of total sales from the US, showing a higher dependence on the US market than most of its peer group.

Bristol-Myers Squibb Co Headlines

No Headlines